Literature DB >> 3135293

Requirement for extracellular calcium or magnesium in mitogen-induced activation of human peripheral blood lymphocytes.

J F Modiano1, E Kelepouris, J A Kern, P C Nowell.   

Abstract

The importance of calcium in lymphocyte activation is well recognized, but the levels of extracellular ionized free calcium (Ca++) necessary for lymphocyte proliferation via various pathways have not been investigated in detail. We studied the ability of a lectin mitogen (PHA) and a calcium ionophore (ionomycin) to induce interleukin 2 receptors, interleukin 2 (IL2) production, and proliferation over various concentrations of extracellular Ca++. Reducing the Ca++ levels from the normal 200 microM to 10 microM in PHA-stimulated cultures partially inhibited IL2 receptor expression, IL2 production, and subsequent proliferation. At 1 microM Ca++, both IL2 activity and proliferation were eliminated, but partial IL2 receptor expression was still observed. Ionomycin did not induce any of these events in cultures where the extracellular Ca++ concentration was below 100 microM. Restoring calcium in the medium resulted in normal levels of IL2 receptor expression, IL2 activity, and proliferation when PBL were stimulated with either mitogen. Exogenous magnesium partially restored these events in PHA-stimulated cultures, but had no effect when ionomycin was used as the mitogen. These data indicate that stimulation by ionomycin is much more dependent upon the levels of extracellular Ca++ than is PHA. Extracellular calcium also appears to be necessary subsequent to IL2 receptor acquisition, since the latter was seen without IL2 activity or proliferation at very low extracellular Ca++, and IL2 failed to restore the proliferative response under these conditions. The data also suggest that PHA, but not ionomycin, can activate lymphocytes via a magnesium-dependent pathway, or that PHA has a lower specificity for divalent cation cofactors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135293     DOI: 10.1002/jcp.1041350312

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

Review 1.  Loss of MAGT1 abrogates the Mg2+ flux required for T cell signaling and leads to a novel human primary immunodeficiency.

Authors:  Feng-Yen Li; Michael J Lenardo; Benjamin Chaigne-Delalande
Journal:  Magnes Res       Date:  2011-09       Impact factor: 1.115

2.  The intracellular Ca2+ concentration optimal for T cell activation is quite different after ionomycin or CD3 stimulation.

Authors:  E Donnadieu; G Bismuth; A Trautmann
Journal:  Pflugers Arch       Date:  1995-02       Impact factor: 3.657

Review 3.  Ion channels and transporters in lymphocyte function and immunity.

Authors:  Stefan Feske; Edward Y Skolnik; Murali Prakriya
Journal:  Nat Rev Immunol       Date:  2012-06-15       Impact factor: 53.106

4.  Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes.

Authors:  M Price; S C Lee; C Deutsch
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

5.  Second messenger role for Mg2+ revealed by human T-cell immunodeficiency.

Authors:  Feng-Yen Li; Benjamin Chaigne-Delalande; Chrysi Kanellopoulou; Jeremiah C Davis; Helen F Matthews; Daniel C Douek; Jeffrey I Cohen; Gulbu Uzel; Helen C Su; Michael J Lenardo
Journal:  Nature       Date:  2011-07-27       Impact factor: 49.962

6.  Fc gamma R(CD16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells. Role of Ca2+ in Fc gamma R(CD16)-induced transcription and expression of lymphokine genes.

Authors:  M A Cassatella; I Anegón; M C Cuturi; P Griskey; G Trinchieri; B Perussia
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

7.  Inactivation of TRPM7 kinase in mice results in enlarged spleens, reduced T-cell proliferation and diminished store-operated calcium entry.

Authors:  Pavani Beesetty; Krystyna B Wieczerzak; Jennifer N Gibson; Taku Kaitsuka; Charles Tuan Luu; Masayuki Matsushita; J Ashot Kozak
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.